Article Text

Download PDFPDF
A characterisation of patient drop outs in a cohort of HIV positive homosexual/bisexual men and intravenous drug users
  1. W K Poolea,
  2. R Perritta,
  3. K B Shaha,
  4. Y Loub,
  5. J Turnerc,
  6. P Kvaled,
  7. P C Hopewellc,
  8. J Glassrothe,
  9. M Rosenf,
  10. L Reichmang,
  11. J Wallaceh,
  12. the Pulmonary Complications of Immunodeficiency Virus Infection Study Group
  1. aResearch Triangle Institute, Research Triangle Park, North Carolina, USA, bGlaxo-Wellcome, Research Triangle Park, cUniversity of California, San Francisco, San Francisco, California, USA, dHenry Ford Hospital, Detroit, Michigan, USA, eUniversity of Wisconsin, Madison, Wisconsin, USA, fBeth Israel Medical Center, New York, USA, gUniversity of Medicine and Dentistry at New Jersey, Newark, New Jersey, USA, hUniversity of California, Los Angeles, Los Angeles, California, USA
  1. Dr Poole, 3040 Cornwallis Road, PO Box 12194, Research Triangle Park, NC 27709–2194, USA (poo{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Enrollees in a study who cease participation for one reason or another can create problems for those who analyse and interpret the data. These problems include loss of statistical power, bias in the study results, and lack of generalisability of the study findings. Whether the study is a clinical trial or an observational study these problems may exist. In trials, for example, non-random withdrawals may compromise the comparability between the treatment groups and hence introduce a bias and in observational studies selective withdrawal may limit the generalisability of the study results. Much has been written about the consequences of non-random withdrawals and some authors have offered statistical techniques that can effectively adjust for the resulting bias if certain assumptions are met. Although it is not generally possible to compensate for all of the problems created by attrition, certain considerations like statistical power and adequate representation of important subgroups can …

View Full Text


  • Funding: supported by contract numbers N01-HR7–8029, 6030, 6031, 6032, 6033, 6034, and 6035 from the National Heart, Lung, and Blood Institute and the National Institute of Allergy and Infectious Diseases and by grant award numbers UO1-HL48534–01, UO1-HL48511–01, UO1-HL48500–01, UO1-HL48518–01, UO1-HL48779–01, UO1-HL48501–01, and UO1-HL48516–01.

  • Conflicts of interest: none.